Molecular Profiling Protocol (SCRI-CA-001)
Launched by SCOTTSDALE HEALTHCARE · Sep 14, 2007
Trial Information
Current as of July 04, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Metastatic cancer which has progressed on 2 prior chemotherapeutic, hormonal or biological regimens for advanced disease.
- • Be defined as refractory to the last line of therapy
- • Have documentation of the best clinical response to the treatment regimen immediately prior to entering this study
- Exclusion Criteria:
- • Patients with symptomatic CNS metastasis
- • Any previous history of another malignancy within 5 years of study entry
- • Uncontrolled intercurrent illness
- • Known HIV, HBV, HCV infection
- • Pregnant or breast-feeding
About Scottsdale Healthcare
Scottsdale Healthcare is a leading provider of comprehensive healthcare services dedicated to advancing medical innovation and improving patient outcomes through clinical research. With a commitment to excellence, Scottsdale Healthcare collaborates with physicians, researchers, and industry partners to conduct rigorous clinical trials across various therapeutic areas. The organization prioritizes patient safety and ethical standards, ensuring that all research initiatives are designed to meet regulatory requirements while enhancing the understanding of new treatments and therapies. Through its robust infrastructure and expertise, Scottsdale Healthcare aims to contribute significantly to the advancement of medical science and the enhancement of community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Scottsdale, Arizona, United States
Tyler, Texas, United States
Indianapolis, Indiana, United States
Beverly Hills, California, United States
Greenville, South Carolina, United States
Huntsville, Alabama, United States
Scottsdale, Arizona, United States
Los Angeles, California, United States
San Antonio, Texas, United States
Patients applied
Trial Officials
Daniel D Von Hoff, MD
Principal Investigator
TGen Clinical Research Services at Scottsdale Healthcare
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials